🔗 Share this article

Texas Attorney General Ken Paxton is suing the producers of Tylenol, claiming the corporations concealed alleged dangers that the pain reliever posed to pediatric cognitive development.

This legal action comes four weeks after Donald Trump advocated an unproven link between taking Tylenol - also known as paracetamol - during pregnancy and autism spectrum disorder in offspring.

The attorney general is suing the pharmaceutical giant, which once produced the drug, the sole analgesic approved for women during pregnancy, and Kenvue, which currently produces it.

In a official comment, he claimed they "misled consumers by making money from discomfort and promoting medication ignoring the potential hazards."

The manufacturer states there is no credible evidence connecting Tylenol to autism.

"These manufacturers misled for generations, intentionally threatening countless individuals to boost earnings," Paxton, from the Republican party, stated.

The company commented that it was "deeply concerned by the dissemination of inaccurate information on the reliability of acetaminophen and the potential impact that could have on the well-being of women and children in America."

On its website, the company also stated it had "continuously evaluated the applicable studies and there is no credible data that demonstrates a established connection between using acetaminophen and autism spectrum disorder."

Organizations representing physicians and health professionals agree.

The leading OB-GYN organization has said acetaminophen - the key substance in acetaminophen - is one of the few options for expectant mothers to treat discomfort and fever, which can pose major wellness concerns if left untreated.

"In more than two decades of studies on the use of paracetamol in pregnancy, not a single reputable study has successfully concluded that the consumption of paracetamol in any stage of gestation leads to neurological conditions in children," the association stated.

The court filing references current declarations from the former administration in claiming the drug is allegedly unsafe.

Recently, Trump caused concern from health experts when he advised women during pregnancy to "resist strongly" not to consume acetaminophen when ill.

The FDA then published an announcement that medical professionals should contemplate reducing the use of Tylenol, while also declaring that "a proven link" between the drug and autism in minors has remains unverified.

Health Secretary RFK Jr, who supervises the FDA, had vowed in spring to conduct "a massive testing and research effort" that would establish the origin of autism spectrum disorder in a limited time.

But experts advised that finding a single cause of autism - believed by scientists to be the outcome of a complicated interplay of inherited and environmental factors - would prove challenging.

Autism spectrum disorder is a form of permanent neurological difference and condition that affects how people encounter and interact with the world, and is identified using medical professional evaluations.

In his legal document, Paxton - who supports Trump who is campaigning for federal office - claims the manufacturer and J&J "intentionally overlooked and tried to quiet the research" around acetaminophen and autism.

The case attempts to require the companies "destroy any marketing or advertising" that states Tylenol is reliable for expectant mothers.

The court case parallels the complaints of a assembly of guardians of minors with autism spectrum disorder and ADHD who filed suit against the manufacturers of Tylenol in recently.

A federal judge dismissed the legal action, declaring research from the parents' expert witnesses was lacking definitive proof.